| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 239.50M | 245.10M | 241.40M | 247.10M | 195.20M | 165.30M |
| Gross Profit | 117.40M | 164.90M | 32.40M | 161.80M | 129.80M | 104.50M |
| EBITDA | 36.60M | 37.90M | 38.40M | 31.70M | 23.80M | 19.00M |
| Net Income | 14.50M | 15.10M | 17.10M | 11.80M | 10.20M | 4.60M |
Balance Sheet | ||||||
| Total Assets | 198.10M | 278.70M | 238.00M | 249.70M | 195.10M | 194.80M |
| Cash, Cash Equivalents and Short-Term Investments | 16.40M | 22.00M | 17.80M | 19.30M | 10.50M | 19.90M |
| Total Debt | 33.30M | 86.10M | 57.80M | 68.80M | 35.80M | 53.20M |
| Total Liabilities | 190.30M | 211.30M | 187.80M | 210.60M | 189.30M | 200.90M |
| Stockholders Equity | 5.10M | 67.40M | 50.20M | 39.10M | 5.80M | -6.10M |
Cash Flow | ||||||
| Free Cash Flow | 24.00M | 11.50M | 22.00M | 8.30M | 14.00M | 23.60M |
| Operating Cash Flow | 35.30M | 25.00M | 32.20M | 16.70M | 19.30M | 26.70M |
| Investing Cash Flow | -36.00M | -35.40M | -14.80M | -22.90M | -5.60M | -2.90M |
| Financing Cash Flow | 1.50M | 15.80M | -20.10M | 14.10M | -21.90M | -22.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £105.21M | 25.21 | 3.19% | 7.67% | -21.14% | -75.01% | |
66 Neutral | £1.70B | 69.38 | 18.87% | 0.60% | 14.88% | 45.73% | |
65 Neutral | £159.03M | 24.22 | 5.87% | 1.03% | 14.49% | 76.33% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ― | ― | ― | 106.64% | ― | ― | |
60 Neutral | £559.38M | 20.35 | 8.04% | 5.18% | -7.30% | -59.71% | |
56 Neutral | £112.77M | ― | -17.46% | ― | 21.17% | -237.25% |